Which of the following is an SGLT 2 inhibitor approved for treatment of type 2 diabetes Mellitus: (A) Dulaglutide, (B) Pramilintide, (C) Canagliflozin, (D) Nateglinide
Answer is C. Canagliflozin, empagliflozin, dapagliflozin, remogliflozin are sglt 2 inhibitors approved for treatment of type 2 diabetes Ref Harrison 20th edi page no 2866, table 397-5